Sentinel node biopsy is a sensitive and reliable sampling technique for determining the axillary status of patients with invasive breast carcinoma. The procedure is particularly suitable for patients with either small palpable or non-palpable tumors who may not need routine axillary lymph node dissection. When SN is found to be negative, unnecessary axillary exploration is avoided, thereby minimizing morbidity. However, success of the procedure is dependent upon the experience of both the surgeon and pathologist. The labeling methods, dyes, and radioisotopes used for the procedure, however, are still not standardized up to date. There is no complete agreement with respect to the type, volume, site of injection, and interval between injection of the labeling agent and surgery. The combined use of radioisotope plus blue dye has been shown to have a higher rate of SN detection by either method alone.